Zoledronic Acid News and Research

RSS
Zoledronic acid is a drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with other drugs to treat multiple myeloma and to prevent bone fractures and reduce bone pain in people who have cancer that has spread to the bone. It is a type of bisphosphonate. Also called zoledronate and Zometa.
Intravenous bisphosphonates drugs increase odds of jaw or face-bone disease

Intravenous bisphosphonates drugs increase odds of jaw or face-bone disease

Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosis

Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosis

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Loyola researchers hope that zoledronic acid will be effective and safe for patients with inflammatory bowel diseases (IBD)

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Zometa reduces bone loss in patients receiving breast cancer treatment

Zometa reduces bone loss in patients receiving breast cancer treatment

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

Link found between bisphosphonates and a serious bone disease called osteonecrosis of the jaw

First filing for zoledronic acid in metabolic bone disease

First filing for zoledronic acid in metabolic bone disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.